3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Small Cell Lung Carcinoma
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Lymphoma, Large B-Cell, Diffuse
11
Lung Neoplasms
10
Burkitt Lymphoma
9
Leukemia, Myeloid, Acute
8
Lymphoma
7
Hodgkin Disease
6
Carcinoma, Non-Small-Cell Lung
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Neoplasms
5
Multiple Myeloma
5
Lymphoma, Non-Hodgkin
5
Lymphoma, B-Cell
5
Sarcoma, Ewing
3
Sarcoma
3
Rhabdomyosarcoma
3
Rhabdoid Tumor
3
Retinoblastoma
3
Recurrence
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Neuroblastoma
3
Neoplasms, Germ Cell and Embryonal
3
Myelodysplastic Syndromes
3
Medulloblastoma
3
Lymphoma, Mantle-Cell
3
Lymphoma, Follicular
3
Leukemia
3
Immunoblastic Lymphadenopathy
3
Seminoma
2
Interventions
Vincristine
1
Platinum Compounds
1
Melphalan
1
Lasers, Semiconductor
1
Lasers
1
Etoposide
1
Drug Therapy
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Retinal Neoplasms
×
Etoposide
×
Clear all
NCT02866136
2025-11-24
RETINO2011
Institut Curie
Phase 2
Active not recruiting
133 enrolled